Attacking Neurodegeneration by Reducing Neurotoxic Proteins and Therefore Improving
AXONAL TRANSPORT
We enhance the FLOW of information along the information highway of nerve cells
WE ARE DEVELOPING DRUGS FOR ALZHEIMER’S DISEASE AND PARKINSON’S DISEASE, INCLUDING THE ORPHAN INDICATION DEMENTIA AND ALZHEIMER’S IN DOWN SYNDROME
Our novel approach to addressing chronic and acute neurodegeneration offers new hope in the fight against the largest unmet need of an aging population
5.8M
Americans with Alzheimer's Disease
Increase in Alzheimer diagnoses by 2060
3x
Failed drug development attempts since 1998
130
Neurotoxic proteins reduce axonal transport and cause a
TOXIC CASCADE
Impaired axonal transport lowers levels of neurotransmitters and neurotrophic proteins leading to nerve cell death.
